Unravelling the heterogeneity of non insulin dependent diabetes

Journal of the Royal College of Physicians of London

Volumn 34, Issue 4, 2000, Pages 332-335

  Pearson, Ewan R ^b   Hattersley, Andrew T ^a  

^a School of Postgraduate Medicine and Health Sciences   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; INSULIN;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; COMORBIDITY; DISEASE CLASSIFICATION; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; SHORT SURVEY; WOLFRAM SYNDROME;

ADOLESCENT; ADULT; AGE OF ONSET; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED;

EID: 0033870207     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (14)

1. O'Rahilly S, Spivey RS, Holman RR, Nugent Z, et al. Type II diabetes of early onset: a distinct clinical and genetic syndrome? Br Med J 1987;294:923-8.
2. Zimmet P, Turner R, McCarty D, Rowley M, et al. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diabetes Care 1999;22(Suppl 2):B59-64.
3. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with non-insulin-dependent onset of disease. Diabetes 1993;42:358-62.
4. Groop LC, Bottazzo GF, Doniach D. Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 at diagnosis. Diabetes 1986;35:237-41.
5. Tattersall RB. Mild familial diabetes with dominant inheritance. Q J Med 1974; 43:339-57.
6. Hattersley AT. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet Med 1998;15:15-24.
7. Maassen JA, Kadowaki T. Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 1996; 39:375-82.
8. Inoue H, Tanizawa Y, Wasson J, Behn P, et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 1998;20: 143-8.
9. Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995; 346:1458-63.
10. Beales PL, Elcioglu N, Woolf AS, Parker D, et al. New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet 1999;36: 437-46.
11. Holm VA, Cassidy SB, Butler MG, Hanchett JM, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993;91398-402.
12. American Society of Human Genetics/ American College of Medical Genetics Test and Technology Transfer Committee: diagnostic testing for Prader-Willi and Angelman syndromes. Am J Hum Genet 1986;58:1085-8.
13. Marshall JD, Ludman MD, Shea SE, Salisbury SR, et al. Genealogy, natural history and phenotype of Alstrom syndrome in a large Arcadian kindred and three additional families. Am J Med Genet 1997;73:150-61.
14. O'Rahilly S, Moller DE. Mutant insulin receptors in syndromes of insulin resistance. Clin Endocrinol 1992;36:121-32.